OsteoarthritisPhase 4NCT00251069
Glucosamine Sulphate and Increased Level of Blood Cholesterol
A Phase 4 study testing Glucosamine sulphate in people with Osteoarthritis, run by Slidgigtinstituttet at 1 site in Denmark.
Trial summary
Glucosamine sulphate causes no changes in blood levels of cholesterol Read more about this study
- Who is it for?
- Ages 40 years and olderHealthy volunteers can take part
- Conditions the study is for
- Osteoarthritis
- What is being tested?
- Glucosamine sulphate
- How many people
- 66 participants
- Where
- 1 siteDenmark
- Study dates
- Apr 2005to Aug 2005
- Phase
- Phase 4
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 40 years and older
- All sexes
- Healthy volunteers accepted
- Adult, Older adult
Inclusion Criteria: Osteoarthritic pain, normal blood cholesterol levels -
Exclusion Criteria: Systemic diseases, pregnancy, need of medication besides painkillers
-
Trial locations and contacts
1 site in 1 country.
About this study
Official title: Glucosamine Sulphate and Hypercholesterolaemia
Glucosamine sulphate causes no changes in blood levels of cholesterol
Read the detailed description
The effects on glucosamine sulphate on blood levels of choleterol is measuered in patients with mild to moderate osteoarthritis
- Conditions
- Osteoarthritis
- Being tested
- Glucosamine sulphate
- Keywords
- glucosamine sulphate, osteoarthritis, cholesterol,
- Medical subject headings
- Osteoarthritis
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Glucosamine sulphateDrug
What is being measured
The primary outcome is the main question the study is designed to answer.
Levels of blood cholesterol
Secondary outcomes (1)
Effect of treatment on pain
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted9 Nov 2005 (estimated)
- Study startApr 2005
- Study completionAug 2005
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for OsteoarthritisStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase 4
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Double blind
- Enrolment
- 66 participants
Sponsor and investigators
- Lead sponsor
- Slidgigtinstituttet
- Sponsor type
- University, hospital or other
- Collaborators
- Pharma Nord
- Investigators
- Keld Ostergaard, M.D., Ph.D., Principal investigator, Slidgigtinstituttet
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT00251069
- Sponsor's protocol ID
- EudraCTnr 2005-000541-11
- Status last verified
- Jul 2005
- First submitted
- 7 Nov 2005
- Last updated
- 9 Nov 2005
- Results posted
- No
Study at a glance
From the registry record, last updated by the sponsor on 9 Nov 2005. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Glucosamine Sulphate and Hypercholesterolaemia
- ClinicalTrials.gov ID
- NCT00251069
- Acronym / sponsor ID
- EudraCTnr 2005-000541-11
- Conditions
- Osteoarthritis
- Keywords
- glucosamine sulphate, osteoarthritis, cholesterol,
- Phase
- Phase 4
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 66 participants
- Lead sponsor
- SlidgigtinstituttetUniversity, hospital or other
- Collaborators
- Pharma Nord
- Study start
- Apr 2005
- Study completion
- Aug 2005
- First posted
- 9 Nov 2005 (estimated)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Glucosamine sulphate causes no changes in blood levels of cholesterol
Detailed description
The effects on glucosamine sulphate on blood levels of choleterol is measuered in patients with mild to moderate osteoarthritis
Study design
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Double blind
Who may qualify
- Ages
- 40 years and older
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Adult, Older adult
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Glucosamine sulphate | Drug | – |
Primary outcome
Levels of blood cholesterol
1 secondary outcome
Effect of treatment on pain
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 9 Nov 2005.
Related trials for Osteoarthritis
Not yet recruiting
Holistic Healing for Knee Osteoarthritis
Knee Osteoarthritis (Knee OA)
Active, not recruiting
Effectiveness of Therapeutic Exercises on Spinopelvic Mobility
Osteoarthritis (OA) of the Hip
Recruiting
Effect of Anti-inflammatory Diet in Osteoarthritis
Osteoarthritis, Knee
Active, not recruitingPhase 2/3
Single vs Triple Hyaluronic Acid in Knee Osteoarthritis
Osteoarthritis, Knee
Not yet recruiting
The Feasibility of a Virtual/Home-based OA Treatment Program in Older Adults With OA and Multimorbidity
Osteoarthritis of the Knee
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Keld Ostergaard, M.D., Ph.D. principal investigator
Slidgigtinstituttet
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A Phase 4 study testing Glucosamine sulphate in people with Osteoarthritis, run by Slidgigtinstituttet at 1 site in Denmark.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 9 Nov 2005. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Denmark. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
What does this phase mean?
Phase 4 studies take place after a treatment is approved, to learn more about its long-term benefits and risks in everyday use.
Not every study follows the same path, and some studies (observational studies, device studies) have no phase.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Levels of blood cholesterol. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 9 Nov 2005.